Although it is an interesting point, several factors can modify HLA-G levels of expression that diverge from the regulation of classic class I HLA molecules [24], such as inflammation and cellular stress [23, 25], making it difficult to link the effect of genetic variants with HLA-G expression in the context of an evolving pathology like cancer. This evidence concerns the gene HLA-G and cancer.